Aura uses high-throughput computational design and lab automation to accelerate protein development for biotech startups and CROs. Spun out from Monash University's Department of Biochemistry, the platform has reduced design cycles from 18 months to 4 months. The company is currently running pilot collaborations with two ASX-listed pharma companies.